EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N‐methyl‐D‐aspartate receptors

Louison Pineau, Emmanuelle Buhler, Sarah Tarhini, Sylvian Bauer, Valérie Crepel, Françoise Watrin, Carlos Cardoso, Alfonso Represa, Pierre Szepetowski iD, Nail Burnashev iD

Epilepsia · 2024

DOI: 10.1111/epi.18000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Louison Pineau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale, Aix-Marseille University, Marseille, France. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, TOR Serine-Threonine Kinases, Neurons. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union Seventh Framework Program FP7.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Genetic variations in proteins of the mechanistic target of rapamycin (mTOR) pathway cause a spectrum of neurodevelopmental disorders often associated with brain malformations and with intractable epilepsy. The mTORopathies are characterized by hyperactive mTOR pathway and comprise tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II. How hyperactive mTOR translates into abnormal neuronal activity and hypersynchronous network remains to be better understood. Previously, the role of upregulated GluN2C‐containing glutamate‐gated N‐methyl‐D‐aspartate receptors (NMDARs) has been demonstrated for germline defects in the TSC genes. Here, we questioned whether this mechanism would expand to other mTORopathies in the different context of a somatic genetic variation of the MTOR protein recurrently found in FCD type II.

Methods

We used a rat model of FCD created by in utero electroporation of neural progenitors of dorsal telencephalon with expression vectors encoding either the wild‐type or the pathogenic MTOR variant (p.S2215F). In this mosaic configuration, patch‐clamp whole‐cell recordings of the electroporated, spiny stellate neurons and extracellular recordings of the electroporated areas were performed in neocortical slices. Selective inhibitors were used to target mTOR activity and GluN2C‐mediated currents.

Results

Neurons expressing the mutant protein displayed an excessive activation of GluN2C NMDAR‐mediated spontaneous excitatory postsynaptic currents. GluN2C‐dependent increase in spontaneous spiking activity was detected in the area of electroporated neurons in the mutant condition and was restricted to a critical time window between postnatal days P9 and P20. Significance Somatic MTOR pathogenic variant recurrently found in FCD type II resulted in overactivation of GluN2C‐mediated neuronal NMDARs in neocortices of rat pups. The related and time‐restricted local hyperexcitability was sensitive to subunit GluN2C‐specific blockade. Our study suggests that GluN2C‐related pathomechanisms might be shared in common by mTOR‐related brain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateTOR Serine-Threonine KinasesNeuronsAnimalsRatsFemaleMalformations of Cortical DevelopmentDisease Models, AnimalRats, Sprague-DawleyPatch-Clamp TechniquesMalformations of Cortical Development, Group IFocal Cortical DysplasiaEpilepsy

Stichwörter der Autor:innen

FCDNMDARmTORopathiesneuron

Substanzen

Receptors, N-Methyl-D-AspartateTOR Serine-Threonine KinasesNR2C NMDA receptormTOR protein, rat

Autor:innen und Institutionen

  • Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale, Aix-Marseille University, Marseille, France.

ORCID-Profile: Pierre Szepetowski, Nail Burnashev

Förderung

  • European Union Seventh Framework Program FP7

Zitieren

APA

Pineau, L., Buhler, E., Tarhini, S., Bauer, S., Crepel, V., Watrin, F., Cardoso, C., Represa, A., Szepetowski, P., & Burnashev, N. (2024). Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N‐methyl‐D‐aspartate receptors. Epilepsia. https://doi.org/10.1111/epi.18000

Vancouver

Pineau L, Buhler E, Tarhini S, Bauer S, Crepel V, Watrin F, et al. Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N‐methyl‐D‐aspartate receptors. Epilepsia. 2024. doi:10.1111/epi.18000

BibTeX
@article{Pineau2024,
  author = {Pineau, Louison and Buhler, Emmanuelle and Tarhini, Sarah and Bauer, Sylvian and Crepel, Valérie and Watrin, Françoise and Cardoso, Carlos and Represa, Alfonso and Szepetowski, Pierre and Burnashev, Nail},
  title = {Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N‐methyl‐D‐aspartate receptors},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.18000}
}
Kostenlos starten →